Introduction. Equine Hyperkalemic Periodic Paralysis ( HYPP ) is a familial, dominant, autosomal musculus disease caused by a missense point mutant in the I±-subunit of the ( SCN4A ) cistron of skeletal musculus voltage-gated Na channel ( VGSC ) 1-11. The disease chiefly affects Quarter Horses ( but besides American Paint Horses and Appaloosas ) and is believed to be confined to posterities of a individual one-fourth Equus caballus entire – Impressive10-15. It was late estimated that around 4 % of the Quarter Equus caballus population could be affected1. HYPP is characterized by sporadic onslaughts of musculus shudders, failing and/or collapse9. Plasma K concentrations are normally elevated during episodes2, 8. Affected Equus caballuss appear clinically normal between episodes. HYPP in Equus caballuss is homologous to the human familial upset besides known as Adynamia Episodica Hereditaria that was foremost reported in the mid-1950s ( 4,5,16 ) , nevertheless it does look to be more serious in Equus caballuss as a few have died during attacks.8 ; 10 ; 17. It was foremost reported in Equus caballuss in the mid 1980s18,19.
Pathophysiology. Several surveies in early 1990s linked this disease to a defect in the electromotive force gated Na channel2, 20. Subsequent surveies lead to the localisation of the defect to a individual point mutant ( C to guanine ) in the cytoplasmatic terminal of S3 in sphere IV of the I±-subunit of the SCN4A gene3, 21, 22. The SCN4A cistron was mapped to chromosome 11 at 14247699-142752891. This alteration in a individual base brace consequences in permutation of the amino acid phenylalanine for leucine at amino acid 1419 ( F1419L ) 10, 21, 23, 24. VGSCs are protein composites widely expressed in nervus and musculus tissue composed of a principal fractional monetary unit which forms the ion pore through which ions can go making an electrical current that allow the extension of musculus action potencies in excitable cells 22, 25-30. During the initial stage of the action potency, the typical resting VGSC activates ( clears ) in response to membrane depolarisation ensuing in a rapid addition in Na+ permeableness due to favorable electrical and chemical gradients and inactivates within a few msecs following repolarization ( 6,22, 27,28, 31,32 ) .. The I±-subunit creases into four homologous spheres ( I- IV ) each with six transmembrane I±-helical sections ( S1- S6 ) 33-38. The electromotive force detector is located in the S4 section of each sphere and contains positively charged amino-acid ( arising from arginine or lysine ) residues and plays an of import function in channel activation35,37. The cytoplasmatic linker that connects domains III and IV serves as an inactivation gate binding to the intracellular pore of the channel to demobilize it25,32. One survey found that the omission of or mutant of aminic acids lead to the riddance of fast inactivation in the channel39. A hydrophobic three of amino acid residues ( isoleucine-phenylalanine-methionine ) form the inactivation gate receptor and is critical for fast inactivation25,32. In Equus caballuss with HYPP, a lasting defect in ion conveyance across the skeletal musculus cell membrane because of the phenylalanine to leucine permutation consequences in a failure of Na channels to demobilize when K+ concentrations are increased. This causes Na to leak into musculus cells through the faulty pores and a decrease of the electrical gradient across the membrane which in bend leads an addition in the concentration of extracellular K+ doing the addition of musculus cell irritability and relentless depolarization6,7,30-34. Potassium, excessively, plays a portion in the defect because it is the chief intracellular ion in the organic structure and its degrees are critical to normal homeostasis. Potassium concentrations are besides really of import for keeping resting membrane potency and neuromuscular every bit good as holding an of import function in the synthesis of DNA and proteins40.
Symptoms. This disease exhibits uncomplete penetrance, intending Equus caballuss with the disease demo significant clinical variableness. Some Equus caballuss will expose no symptoms at all while others will expose terrible episodes of periodic palsy and some Equus caballuss have died normally from cardiac apprehension and/or respiratory failure10,19,41,42. The is besides a big variableness in the continuance of episodes that could last anyplace from 15-90 minutes18 and could last for much longer if non treated34. The oncoming of episodes is really unpredictable. Episodes may get down with a brief period of myotonia ( musculus stiffness ) , with some Equus caballuss demoing prolapsus of the 3rd eyelid, hypotonus ( jerking or delayed relaxation of musculuss ) and musculus fasciculations that are noticed ab initio in the wings, cervix and shoulders. Weakness that may attest as swaying and staggering is besides a common sign1,5,6,7,10,18,21,42-44. In more terrible instances horses prostration into nonvoluntary recumbency, Respiratory stridor due to palsy of upper respiratory musculuss, guttural prostration, and laryngeal palsy is chiefly seen in foals that are homozygous ( H/H ) for HYPP. Although foals heterozygous ( N/H ) have been known to expose similar marks they are normally less badly affected45,46. Factors implicated in the triggering of HYPP episodes include sudden dietry alterations, diets that contain & gt ; 1.1 % of K in the entire day-to-day intake 1,5,42-44,47, local anesthetic47,48 which act by barricading Na flux through VGSCs49, fasting and physical emphasis during ablactating or in conveyance. The factor ( s ) responsible for variableness in symptoms between HYPP affected Equus caballuss is non yet known. However some suggestions have included direction factors. interesting study50 found that symptomless Equus caballuss had more normal Na channel messenger RNA, while diagnostic Equus caballuss had more mutant messenger RNA proposing a molecular mechanism behind clinical variableness. However, a figure of restrictions in this survey have cast uncertainty over the consequences. First, the sample figure was little ( n=28 ) , and there was besides high experimental mistakes for at least two of the Equus caballuss and there was a important convergence of values between Equus caballuss.
Diagnosis. Initially, diagnosing can be based on posterities of Impressive on the sire ‘s or dike ‘s side together with clinical marks such as sporadic onslaughts of musculus shudders, failing, or recumbency are strongly implicative of HYPP. Plasma K concentrations are normally elevated during and for about one to two hours after the
episodes in affected horses10 but that is non ever the instance as some surveies have found Equus caballuss to hold normal plasma K concentrations even in terrible cases47,51. Although these are strong indicants of HYPP, they are non unequivocal. Prior to the development of the DNA trial, provocative trials were conducted for diagnostic grounds. One such trial was the K chloride challenge trial which involved fasting of Equus caballuss for 12 hours followed by unwritten disposal of ( 88 to 160 mg/kg ) K chloride ( KCl ) mixed in H2O. This induces symptoms in most HYPP affected Equus caballuss normally within two to three hours due to the addition in extracellular K+ concentration52-54. Because of the little dosage that is administered, normal Equus caballuss are unaffected by the trial. This trial, nevertheless, is really clip devouring as it involves the close monitoring of Equus caballuss for several hours. Another job with this trial is that the dosage of KCL needs to be increased until symptoms appear which increases the hazard of bring oning a terrible onslaught and has in some instances proved to be fatal53. Electromyography ( EMG ) has besides been used as a diagnostic assistance for equine HYPP47,53 by observing unnatural EMG signals due to increased muscular contraction. High-frequency myotonic discharges and doublets are the most sensitive and specific for HYPP47. One survey found that EMG in combination with K challenge proving gave the most accurate diagnosis53. Although EMG is a utile, fast and safe diagnostic tool it has been far superseded in truth by cistron investigation for the Deoxyribonucleic acid that codes for the faulty Na channel which has proved to be the most sensitive and specific trial for HYPP to date54.
Treatment. For exigency intervention during a mild onslaught, light exercising either by walking or hurling is normally recommended in order to excite the secernment of epinephrine which causes an addition in the Na+/K+ pump activity that helps replace K inside cells. Oral disposal of acetazolamide ( 2.2- 4.4 mg/kg ) two to three times a twenty-four hours. Acetazolamide is a mild K+ blowing diuretic that increases K+ elimination from the kidney, stabilises blood glucose and K+ and plants by diminishing the resorption of Na, chloride and hydrogen carbonate in the proximal tubules. It is chiefly used in handling worlds with HYPP but has been found to be effectual for handling Equus caballuss every bit good but pharmacokinetics of acetazolamide has non been studied in Equus caballuss. The most normally used method for handling terrible episodes of HYPP is the endovenous disposal of 100 milliliters 23 % Ca gluconate diluted in 1 L of 5 % dextroglucose or saline entirely or combined with Na hydrogen carbonate. Phenytoin, an antiepileptic, has been used efficaciously in handling a broad scope of skeletal musculus upsets It decreases or eliminates the marks of HYPP by cut downing Na and Ca currents in cells55,56.
Management. The most of import facet of long term direction of Equus caballuss with HYPP is dietetic direction. A survey by Reynolds II + III found that clinical marks were induced when HYPP affected Equus caballuss were fed higher K diets. Horses did non demo any symptoms when diet A ( incorporating 1.1 % K in entire rations ) was fed. However, when dietetic K was increased to 1.9 % ( diet B ) and 2.9 % ( diet C ) horses showed frequent clinical marks along with an addition in plasma K+ concentrations which resulted from potassium soaking up from the rations. HYPP affected Equus caballuss should hence be fed diets incorporating 1.1 % K+ or less. Horses should besides be allowed free grazing land or paddock exercise41.
Selection. Before HYPP was discovered in Equus caballuss a Quarter Horse entire named Impressive has had a enormous sum of success winning all the competitions he was entered into. Because of his success and look of a super-muscular phenotype, Impressive was really sought after by Quarter Horse, Appaloosas and Paints breeders. By the clip HYPP was linked to Impressive 20 old ages ago he had already had a profound impact on the genetic sciences of Quarter Horse strain and has shown no mark of decelerating down. It was ab initio hoped that with the increasing consciousness of the disease and the development of familial proving for HYPP breeders would be loath to engender their Equus caballus with one which they knew was positive for HYPP. However, that has non been the instance and it seems clear that HYPP is being actively selected for due to high success of these Equus caballuss. It was late estimated that around 4 % of the Quarter Equus caballus population could be affected with around 366,000 of Impressives ‘ offspring registered with the American Quarter Horse Association ( AQHA ) and five million around the world21. The AQHA has played a major function in footings of support scientific surveies into equine HYPP. However their function in seeking to restrict or extinguish this disease is instead questionable. It about seems as if the AQHA is encompassing the disease and is seeking to work with it instead than against it. Their determination to deny enrollment to homozygous affected foals born in 2007 or subsequently merely means that these Equus caballuss would non be able to vie. Engendering two heterozygous Equus caballuss would still intend a 25 % opportunity of a homozygous foal being produced. An estimated 10 % of most severly affected Equus caballuss have died59.
Decision. Although there is no scientific grounds to propose that HYPP Equus caballuss ‘ musculuss are different than normal Equus caballuss, the immense success of Impressive and his posterities is undeniable. As human existences, breeders are driven by success and that can sometimes take to them turning a blind oculus to whatever side effects that success might convey with it. The breeders chief statement is that HYPP is a absolutely manageable disease and most Equus caballuss lead a really successful life healthy lives proper direction and medicine. Although this is slightly true, the other side of the coin still exists where some Equus caballuss suffer a great trade and stop up deceasing as a direct consequence of this disease. This raises serious ethical concerns If HYPP is to be eliminated, steadfast action by the AQHA is necessary as breeders will non halt engendering HYPP affected Equus caballuss if there is nil to forestall them. A great trade of information is now known
Finno, C. J. , Spier, S. J. , and Valberg, S. J. 2009. Equine diseases caused by known familial mutants. The Veterinary Journal, 179 ( 3 ) , pp. 336-347.
Cannon, S. C. , Brown, R. H. , and Corey, D. P. 1991. A sodium channel defect in
hyperkalemic periodic palsy: potassium-induced failure of inactivation.
Neuron, 6, pp. 619-626.
Rudolph, J. A. , Spier, S. J. , Byrns, G. , Rojas, C. V. , Bernoco, D. , and Hoffman, E. P. 1992. Periodic palsy in Quarter Horses: a Na channel mutant disseminated by selective genteelness. Nat Genet, 2, pp.144-147.
Rudolph, J. A. , Spier, S. J. , Byrns, G. , and Hoffman, E. P. 1992. Linkage of hyperkaelemic periodic palsy in Quarter Horses to the Equus caballus grownup skeletal musculus Na channel cistron. Anim Genet 23, pp. 241-50.
Meyer, T. S. , Fedde, M. R. , Cox, J. H. , and Erickson, H. H. 1999. Hyperkalaemic periodic palsy in Equus caballuss: a reappraisal. Equine vet. J. , 31 ( 5 ) , pp. 362-367.
Naylor, J. M. 1994. Equine hyperkalemic periodic palsy: Reappraisal and deductions. Can Vet J. , 35, pp. 279-285.
Spier, S. J. 2006. Hyperkalemic Periodic Paralysis: 14 Old ages Subsequently. AAEP proceedings, 52, pp. 347-350.
Jurkat-Rott, K. , and Lehmann-Horn, F. 2007. Genotype-Phenotype Correlation and Therapeutic Rationale in Hyperkalemic Periodic Paralysis. The Journal of the American Society for Experimental NeuroTherapeutics, 4 ( 2 ) , pp, 216-224.
Zeilmann, M. 1993. HYPP — hyperkalemic periodic palsy in Equus caballuss. Tierarztl Prax. , 21 ( 6 ) , pp. 524-527.
Aleman, M. 2008. A reappraisal of equine musculus upsets. Neuromuscular Disorders, 18, pp. 277-287.
Steele, D. S. , and Naylor, J. M. 1996. Hyperkalemic periodic palsy, plasma lactate and exercising tolerance. Journal of Equine Veterinary Science, 16 ( 8 ) , pp. 327-333.
Cox, J.H. 1993. Hyperkalemic periodic palsy: naming the disease in the headlines. Equine Vet J. , 25, pp. 174-177.
Naylor, J.M. , Robinson, J.A. and Bertone. J.J. 1992. Familial incidence of hyperkalemic periodic palsy in Quarter Horses. J Am vet rned. Ass. , 200, pp. 340-343.
Bowling, A. T. , Byrns, G. , and Spier, S. 1996. Evidence for a individual pureblood beginning of the hyperkalemic periodic palsy susceptibleness cistron in Quarter Horses. Anim Genet. , 21, pp. 279-281.
Naylor, J. M. , Robinson, J. A. , Crichlow, E. C. and Steiss, J. E. 1992. Inheritance of Myotonic Discharges in American Quarter Horses and the Relationship to Hyperkalemic Periodic Paralysis. Can J Vet Res, 56, pp. 62-66.
Pickar, J. G. , Spier, S. J. , Snyder, J. R. and Carlsen, R. C. 1991. Altered ionic permeableness in skeletal musculus from Equus caballuss with hyperkalemic periodic palsy. Am. J. Cell. Physiol.,260, C926-C933.
Lehmann-Horn, F. , and Jurkat-Rott, K. 1999. Voltage-Gated Ion Channels and Hereditary Disease. Physiological reviews, 79 ( 4 ) , pp. 1317- 1372.
Cox, J. H. 1985. An episodic failing in four Equus caballuss associated with intermittent serum hyperkalemia and the similarity of the disease to hyperkalemic periodic paresis in man.. Proc Am Assoc Equine. Practitioners. , 21, pp.383-391.
Steiss, J. E. , and Naylor, J. M.1986. Episodic musculus shudders in a one-fourth Equus caballus: Resemblance to hyperkalemic periodic palsy. Can Vet J. , 27, pp. 332-335.
Ptacek, L. J. , Tyler, F. , Trimmer, J. S. , Agnew, W. S. , and Leppertt, M. 1991. Analysis in a Large Hyperkalemic Periodic Paralysis Pedigree Supports Tight Linkage to a Sodium Channel Locus. Am. J. Hum. Genet. 49, pp. 378-382.
Spier, S. J. , and Hoffman, E. P. 2008. Hyperkalaemic periodic palsy: Mother nature versus human nature. Equine vet. Educ. , 20 ( 8 ) , pp. 401-405.
ULBRICHT, W. 2005. Sodium Channel Inactivation: Molecular Determinants and Modulation. Physiol Rev. , 85, pp. 1271-1301.
West, J. W. , Patton, D. E. , Scheuer, T. , Wang, Y. , Goldin, A. L. and Catterall, W. A. 1992. A bunch of hydrophobic amino acid residues required for fast Na ( + ) -channel inactivation. Proc Natl Acad Sci U S A. , 89 ( 22 ) , pp. 10910-10914.
Brosnahan, M. M. , Brooks, S. A. , and Antczak, D. F. 2010. Equine clinical genomics: A clinician ‘s primer. Equine vet. J. , 42 ( 7 ) , pp. 658-670.
Yu, F. H. , and Catterall, W. A. 2003. Overview of the voltage-gated Na channel household. Genome Biology, 4 ( 3 ) , pp. 207.1-207.7.
Catterall, W. A. , Goldin, A. L. , and Waxman, S. J. 2003. International Union of Pharmacology. XXXIX.Compendium of Voltage-Gated Ion Channels: Sodium Channels. Pharmacol Rev. , 55 ( 4 ) , pp. 575-578.
Catterall, W. A. 2000. From ionic currents to molecular mechanisms: the construction and map of voltage-gated Na channels. Neuron 26, pp. 13-25.
Clare, J. J. , Tate, S. N. , Nobbs, M. , and Romanos, M. A. 2000. Voltage-gated Na channels as curative marks. Drug Discovery Today, 5 ( 11 ) , pp. 506-520.
Angelino, E. , and Brenner, A. E. 2007. Excitability restraints on voltage-gated Na channels. PLoS.Comput.Biol. , 3 ( 9 ) , pp. 1751-1760.
George, A. L. 2005. Inherited upsets of voltage-gated Na channels. J Clin Invest. , 115 ( 8 ) , pp. 1990-1999.
Fontaine, B. , Plassart-Schiesst, E. , and Nicolet, S. 1997. Diseases caused by voltage-gated ion channels. Molec.Aspects.Med. , 18, pp. 415-483.
Hanna, W. J. B. , Tsushima, R. G. , Sah, R. , McCutcheon, L. J. , Marbant, E. , and Backx, P. H. 1996. The equine periodic palsy Nae channel mutant alters molecular passages between the unfastened and inactivated provinces. Journal of Physiology, 497 ( 2 ) , pp.349-364.
Felix, R. 2000. Channelopathies: ion channel defects linked to heritable clinical upsets. J Med Genet. , 37 ( 10 ) , pp. 729-740.
Lyle, C. H. , and Keen, J. A. 2010. Episodic prostration in the Equus caballus. Equine vet. Educ. , 22 ( 11 ) , pp. 576-586.
Bosmans, F. , and Tytgat, J. 2007. Voltage-gated Na channel transition by Scorpio a-toxins. Toxicon, 49, pp. 142-158.
Bezanilla, F. 2005. Voltage-Gated Ion Channels. IEEE minutess on nanobioscience, 4 ( 1 ) , pp. 34-48.
Wood, J. N. , and Baker, M. 2001. Voltage-gated Na channels. Current Opinion in Pharmacology, 1 ( 1 ) , pp.17-21.
GOLDIN, A. L. 1999. Diverseness of Mammalian Voltage-Gated Sodium Channels. Ann N.Y Acad Sci. , 868, pp. 38-50.
Patton, D. E. , West, J. W. , Catterall, W. A. , and Goldin, A. L. 1992. Amino acerb residues required for fast Na channel inactivation. Charge neutralisations and omissions in the III-IV linker. Proc Natl Acad Sci USA. , 89, pp. 10905-10909.
Hoskote, S. S. , Joshi, S. R. , and Ghosh, A. K. 2008. Disorders of Potassium Homeostasis: Pathophysiology and Management. J Assoc Physicians India. , 56, pp. 685-693.
Spier, S.J. 1993. Blood trial available for hyperkalemic periodic palsy in one-fourth Equus caballuss. J equine vet Sci. 13, 140-142.
Reynolds, J. A. , Potter, G. D. , Greene, L. W. , Wu, G. , Carter, G. K. , Martin, M. T. , Peterson, T. V. , Murray-Gerzik, M. , Moss, G. , and Erkert, R. S. 1998. Genetic-diet interactions in the hyperkalemic periodic palsy syndrome in one-fourth Equus caballuss fed changing sums of K: III. The relationship between plasma K concentration and hypp symptoms. Journal of equine veterinary scientific discipline, 18 ( 11 ) , pp. 731-735.
Reynolds, J. A. , Potter, G. D. , Greene, L. W. , Wu, G. , Carter, G. K. , Martin, M. T. , Peterson, T. V. , Murray-Gerzik, M. , Moss, G. , and Erkert, R. S. 1998. Genetic-diet interactions in the hyperkalemic periodic palsy syndrome in one-fourth Equus caballuss fed changing sums of K: portion II-symptoms of HYPP. Journal of Equine Veterinary Science, 18 ( 10 ) , pp. 655-661.
Reynolds, J. A. , Potter, G. D. , Greene, L. W. , Wu, G. , Carter, G. K. , Martin, M. T. , Peterson, T. V. , Murray-Gerzik, M. , Moss, G. , and Erkert, R. S. 1998. Genetic-diet interactions in the hyperkalemic periodic palsy syndrome in one-fourth Equus caballuss fed changing sums of K: I. Potassium and Na balance, packed cell volume and plasma K and Na concentrations. Nutrition and Physiology, 18 ( 9 ) , pp. 591-600.
Traub-Dargatz, J. L. , Ingram, J. T. , Stashak, T. S. , Kiper, M. L. , Tarr, S. , Child, G. , and MacAllister, C. G. 1992. Respiratory stridor associated with polymyopathy suspected to be hyperkalemic periodic palsy in four one-fourth Equus caballus foals. J Am Vet Med Assoc. , 201 ( 1 ) , pp. 85-89.
Carr, E. A. , Spier, S. J. , Kortz, G. D. , Hoffman, E. P. 1996. Laryngeal and pharyngeal disfunction in Equus caballuss homozygous for hyperkalemic periodic palsy. J Am Vet Med Assoc. , 209, pp.798-803.
Robertson, S. A. , Green, S. L. , Carter, S. W. , Bolon, B. N. , Brown, M. P. , Shields, R. P. 1992. Postanesthetic recumbency associated with hyperkalemic periodic palsy in a one-fourth Equus caballus. J Am Vet Med Assoc. , 201 ( 8 ) , pp. 1209-1212.
Bailey, J. E. , Pablo, L. , and Huhhell, J. A. E. 1996. Hyperkalemic periodic palsy episode during halothane anaesthesia in a Equus caballus. J Am vet med Ass. , 208, pp. 1859-1865.
Sah, R. L. , Tsushima, R. G. , and Backx, P. H. 1998. Effectss of local anaesthetics on Na+ channels incorporating the equine hyperkalemic periodic palsy mutant. Am J Physiol Cell Physiol. , 275, pp. 389-400.
Zhou, J. , Spier, S. J. , Beech, J. , and Hoffman, E. P.1994. Pathophysiology of Na channelopathies: correlativity of normal/mutant mRNA ratios with clinical phenotype in dominantly inherited periodic palsy. Hum Mol Genet. , 3, pp. 1599 -1603.
Beech, J. , and Lindborg, S. 1995. Contraceptive efficaciousness of diphenylhydantoin, acetazolamide and hydrochlorothiazide in Equus caballuss with hyperkalaemic periodic palsy. Research in Veterinary Science, 59, pp. 95-101.
Steele, D. S. , and Naylor, J. M. 1996. Hyperkalemic periodic palsy, Plasma lactate and exercising tolerance. Journal of Equine Veterinary Science, 16 ( 8 ) , pp. 327-333.
Naylor, J. M. , Jones, V. , and Berry, S. L. 1993. Clinical syndrome and diagnosing of hyperkalaemic periodic palsy in one-fourth Equus caballuss. Equine Vet J. , 25 ( 3 ) , pp. 227-232.
Bannasch, D. 2008. Familial Testing and the Future of Equine Genomics. Journal of Equine Veterinary Science, 28 ( 11 ) , pp. 645-649.
Beech, J. , Fletcher, J. E. Tripolitis, L. , Lindborg, S. , and Dawso, T. 1995. Consequence of diphenylhydantoin on skeletal musculus from one-fourth Equus caballuss with hyperkalaemic periodic palsy. Research in Veterinary Science, 58 ( 3 ) , pp. 206-211.
Fletcher, J. E. , Erwin, K. , and Beech, J. 1993. Phenytoin additions specific triacylglycerol fatty esters in skeletal musculus from Equus caballuss with hyperkalemic periodic palsy. Biochim Biophys Acta. , 1168 ( 3 ) , pp. 292-298.
Lehmann-Horn, F. , and Rudel, R. 1996. Channelopathies: The Nondystrophic Myotonias and Periodic Paralyses. Seminars in Pediatric Neurology, 3 ( 2 ) , pp. 122-139.
Gordon, E. S. , Dressman, H. A. G. , and Hoffman, E. P. 2005. The genetic sciences of musculus wasting and growing: The impact and deductions of polymorphisms in animate beings and worlds. The International Journal of Biochemistry & A ; Cell Biology, 37, pp. 2064-2074.